Star Lake Bioscience Co., Inc.Zhaoqing Guangdong (SHA:600866)

China · Delayed Price · Currency is CNY

4.250

-0.170 (-3.85%)

Sep 11, 2026, 3:00 PM CST

SHA:600866 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	15,930	15,900	17,334	17,374	17,486	4,071
Revenue Growth	-6.34%	-8.27%	-0.23%	-0.64%	329.51%	264.72%
Gross Profit	1,714	2,550	2,942	2,397	2,998	794.87
Operating Income	293.55	1,180	1,596	1,185	1,762	325.66
Net Income	213.33	978.89	943.15	677.95	608.33	152.14
Earnings Per Share	0.13	0.59	0.57	0.41	0.51	0.19
EPS Growth	-83.24%	3.79%	39.14%	-20.34%	171.58%	-6.26%

Revenue by Segment

Fiscal Year	FY 2025
Period Ending	Dec '25 Dec 31, 2025
Food and Feed Additives	14,595
Biochemical Raw Materials and Pharmaceutical Intermediates	352.21
Organic Fertilizer	344.98
Total	15,293

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	1,506	2,194	1,910	1,425	1,374	1,231
Total Debt	7,216	6,240	3,441	4,314	4,821	4,652
Net Cash (Debt)	-5,710	-4,046	-1,531	-2,889	-3,447	-3,420
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-3.44	-2.44	-0.92	-1.74	-2.90	-4.24

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-113.78	1,292	2,398	2,026	1,663	168.2
Capital Expenditures	-2,041	-2,039	-638.5	-375.83	-452.34	-349.79
Free Cash Flow	-2,155	-746.52	1,759	1,650	1,210	-181.59
Free Cash Flow Growth	-	-	6.60%	36.37%	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	10.76%	16.04%	16.97%	13.80%	17.15%	19.52%
Operating Margin	1.84%	7.42%	9.21%	6.82%	10.08%	8.00%
Pretax Margin	1.78%	7.66%	7.11%	4.97%	8.14%	6.83%
Profit Margin	1.34%	6.16%	5.44%	3.90%	3.48%	3.74%
FCF Margin	-13.53%	-4.70%	10.15%	9.50%	6.92%	-4.46%

Dividends

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Sep '26 Sep 11, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Dividend Per Share	0.380	0.380	0.380	0.380
Dividend Per Share Growth	0%	0%	0%	-
Dividend Yield	8.74%	5.91%	6.69%	9.88%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 11, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	33.08	11.80	11.40	11.42	16.20	30.31
Forward PE	12.88	8.36	9.80	10.13	18.92	18.92
P/FCF Ratio	-	-	6.11	4.69	8.14	-
PS Ratio	0.44	0.73	0.62	0.45	0.56	1.13